Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Physicians Can Deal With & Avoid Negative Online Reviews

In a world filled with online review sites for every type of profession, a positive online reputation is vital to the livelihood of any organization. But a few negative reviews can seriously harm a doctor’s practice, even if the doctor feels as though they have done nothing wrong. Of course, the best thing to do…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In a world filled with online review sites for every type of profession, a positive online reputation is vital to the livelihood of any organization. But a few negative reviews can seriously harm a doctor’s practice, even if the doctor feels as though they have done nothing wrong. Of course, the best thing to do would be to avoid bad reviews altogether; however, there are several strategies for dealing with this type of adverse feedback when it does occur.

A study from UC Davis found that denying a patient’s request is a surefire way to get a negative review. Unfortunately, due to several factors, including patient health and safety, doctors must sometimes deny a patient’s request. So how can healthcare providers walk the fine line between earning high marks and protecting each patient’s wellbeing? Here are a few tips to guide you through such a predicament:

Actively Listen

Even if you know that you must ultimately deny a patient’s request, that person may be more understanding if they feel they have been heard. Pay close attention to what your patient says—you may even discover clues through conversation that can circumvent a total denial of their wishes.

Consider Carefully

While some things patients want may be ineffective or even harmful, others may be genuinely beneficial. Keep in mind that most patients want to take an active role in their healthcare, so carefully consider why the patient may be asking for a particular course of treatment—their request could be based on a friend’s success story, an ad seen on television, or self-conducted cursory research. While you must ultimately make the decision that’s right for your patient, you should never assume that the patient knows nothing about their condition or what they need.

Keep Learning

No matter the sector or industry, no business wants to receive a negative review. However, negative feedback can be particularly frustrating for doctors, especially when their goal is to provide optimum care for their patients. When confronted with a bad review take a moment to see the situation from the patient’s perspective—this can help foster communication with similar patients in the future and may lead to more favorable outcomes.

Furthermore, a response acknowledging that you have seen a particular review can impart to the patient and other viewers that you appreciate honest feedback and are willing to learn from the experience. And the sooner you respond, the better.

Practice Makes Perfect

It’s called a medical “practice” for a reason and as your skills and knowledge continue to evolve, sharpening your communication skills along the way can be vital to your success. Great communicative abilities can help a patient understand the reasoning behind a request being denied and will lead to more understanding and happier patients.

Review sites aren’t going anywhere, and neither are patient requests. Applying these tips in your everyday practice will improve the doctor-patient relationship, resulting in happier and healthier patients, all while improving your online reputation.

Read more at chartlogic.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512